3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
17
Carcinoma, Non-Small-Cell Lung
8
Glioblastoma
7
Carcinoma, Renal Cell
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Brenner Tumor
6
Squamous Cell Carcinoma of Head and Neck
5
Melanoma
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Gliosarcoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Recurrent Squamous Cell Lung Carcinoma
3
Oligodendroglioma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Spinal Cord Neoplasms
2
Medulloblastoma
2
Glioma
2
Endometrial Adenocarcinoma
2
Colonic Neoplasms
2
Carcinoma
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
Everolimus
5
Topotecan
2
Etoposide
2
Cisplatin
2
Bevacizumab
2
veliparib
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
pasireotide
1
lenvatinib
1
carfilzomib
1
cabozantinib
1
berzosertib
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Podophyllotoxin
1
Platinum
1
Octreotide
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Neuroendocrine
×
Immunoglobulin G
×
Clear all
No trials found.